Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp61 | Bone development/growth and fracture repair | ECTS2014

Fas ligand in formation of hard tissues

Svandova Eva , Lesot Herve , Oralova Veronika , Poliard Anne , LeDenmat Dominique , Matalova Eva

Among activation of apoptotic machinery, Fas (CD95)/FasL (CD178) were suggested to act in cell proliferation and differentiation. Expression of Fas and FasL was reported during tooth and bone formation. The examination of gld mice showed increased total body bone mass and number of osteoblasts in long bones. However, Fas and FasL functions in osteogenesis remain controversial. As most of studies dealing with Fas/FasL system in bone formation were performed in endochondral mode...

ba0003pp132 | Cell biology: osteoblasts and bone formation | ECTS2014

Roles of phospholipase D during physiological and vascular calcification

Abdallah Dina , Hamade Eva , Badran Bassam , Buchet Rene , Mebarek Saida

There is a similarity of the mechanisms of physiological and pathological mineralization. Pathological calcification of soft tissues as the case of vascular calcification is characterized by the deposition of hydroxyapaptite induced by matrix vesicles at least in the initial stage as in the case of physiological calcification in skeletal tissues. Lipid metabolism is involved in the differentiation of smooth muscle cells and bone cells suggesting that phospholipases can modulat...

ba0003pp412 | Paediatric bone disease | ECTS2014

Team management of young persons with osteogenesis imperfecta

Hagberg Maud , Lowing Kristina , Malmgren Barbro , Kumlien Catharina , Eva AEstrom

The pediatric osteogenesis imperfecta (OI) team at our university hospital was established in 1991. The multi- and inter-disciplinary team consists of: pediatric neurologist, nurse, nursing assistant, physiotherapist, occupational therapist, orthopedic surgeon, orthotist, radiologist, dentist and geneticist. We also have a close collaboration with other specialists.Our assignment is high qualified diagnostics, functional assessments and also individualiz...

ba0001pp353 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Apolipoprotein-E deficiency prevents obesity but predisposes to the development of osteoporosis following long-term exposure to Western-type diet, in mice

Papachristou Nicholaos , Kalyvioti Elena , Triantaphyllidou Irene-Eva , Karavia Eleni , Plakoula Eva , Blair Harry , Kypreos Kyriakos , Papachristou Dionysios

Introduction: Recent data suggest that imbalances in lipid metabolism affect bone cell function resulting in osteoporosis. Here, we investigated the role of apolipoprotein E (ApoE), essential component of chylomicron and very low density Lipoprotein metabolic pathways, in the regulation of osteoblast and osteoclast function and thus in the pathogenesis of osteoporosis.Material and methods: We used apoE deficient (ApoE−/−) and wild ...

ba0001pp354 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Apolipoprotein A-I deficiency is associated with decreased expression of osteoblast-specific regulators in mice

Kalyvioti Elena , Papachristou Nicholaos , Triantaphyllidou Irene-Eva , Karavia Eleni , Plakoula Eva , Blair Harry , Kypreos Kyriakos , Papachristou Dionysios

Introduction: Recent data suggest that imbalances in lipid metabolism affect the function of both osteoblasts and osteoclasts and thus bone quality. Here we investigated the role of apolipoprotein A-I (ApoA-I), a key-element of HDL biogenesis, in the regulation of cardinal genes/proteins that regulate lipoblasts and osteoblasts in mice.Materials and methods: We used apoA-I deficient (ApoA-I−/−) and wild-type (C57BL/6) mice (10 anim...

ba0001pp1 | Clinical case posters | ECTS2013

Ten years follow up after prenatal transplantation of fetal mesenchymal stem cell in a patient with severe osteogenesis imperfecta

Gotherstrom Cecilia , Blanc Katarina Le , Astrom Eva , Taslimi Jahan , Graham Gail E , Ewald Uwe , Westgren Magnus

Background: Treatment with multipotent mesenchymal stromal cells (MSC) has the potential to ameliorate mesodermal disorders.Objective: To treat severe osteogenesis imperfecta (OI) with fetal MSC.Methods: Ten years ago, we treated a fetus with OI type III (COL1A2: c.3008G>A, p.Gly1003Asp) in utero with fetal HLA-mismatched MSC. The procedure was uncomplicated. At the age of 4 months i.v. pamidronete treatment was starte...

ba0001pp280 | Genetics | ECTS2013

Association between dentinogenesis imperfecta and mutations in COLIA1 and COLIA2 genes

Andersson Kristofer , Dahllof Goran , Astrom Eva , Rubin C-J , Kindmark A , Lindahl Katarina , Ljunggren Osten , Malmgren Barbro

Introduction: Dentinogenesis imperfecta (DI) is a common dental aberration in patients with osteogenesis imperfecta (OI). Mutations that cause abnormal collagen chains will cause more serious types of OI and it has been claimed that DI should be a marker for qualitative defected collagen. It has also been supposed that normal development of teeth may be more dependent on normal α2(I) than normal α1(I) chains which are encoded by COLIA2 and COLIA1 ge...

ba0001pp492 | Other diseases of bone and mineral metabolism | ECTS2013

Allele dependent silencing of collagen type I using small interfering RNAs targeting 3′UTR indels – a novel therapeutic approach in osteogenesis imperfecta

Lindahl Katarina , Kindmark Andreas , Laxman Navya , Astrom Eva , Rubin Carl-Johan , Ljunggren Osten

Abstract: Osteogenesis imperfecta, also known as ‘brittle bone disease’, is a heterogeneous disorder of connective tissue generally caused by dominant mutations in the genes COL1A1 and COL1A2, encoding the α1 and α2 chains of type I (pro)collagen. Symptomatic patients are usually prescribed bisphosphonates, but this treatment is neither curative nor sufficient. A promising field is gene silencing through RNA interference. In this study, small interfering RN...

ba0002p48 | (1) | ICCBH2013

Pubertal induction with testosterone of a boy with bilateral anorchia guided by the development of his monozygotic twin brother

Van Caenegem Eva , Vandewalle Sara , Taes Youri , Kaufman Jean-Marc , Craen Margarita , Guy T'Sjoen

Introduction: We describe a monozygotic twin pair, of which one boy was diagnosed with anorchia. Both were followed-up till age 17.Case report: At birth, in one twin 46 XY boy (A), testes were not palpable while his brother (B) was unaffected. Stimulation with human chorionic gonadotrophin (hCG) and orchidopexia were unsuccessful at age 3. A second hCG-stimulation test was performed at age 8, where serum testosterone response failed to increase. No testi...